To thoroughly implement national decisions and deployments regarding scientific and technological innovation and to help enterprises fully utilize preferential policies on R&D expense pre-plus deductions, the Xingtai Science and Technology Bureau grandly hosted the “R&D Expense Pre-plus Deduction Policy Promotion and Prior Appraisal Outreach Event” on the morning of August 18, 2026, at the Wanfeng Hotel in Xindu District. As a representative innovative enterprise in Xingtai’s magnesium salt technology sector, Hebei Messi Biology Co., Ltd. attached great importance to this training opportunity, sending a delegation composed of the company’s financial director and R&D backbone personnel to attend the meeting.
During the conference, expert lecturers provided an easy-to-understand interpretation of the preferential tax policies for pre-tax plus deductions of corporate R&D expenses, focusing on detailed analyses of the definition of R&D activities, the scope of expense collection, application procedures, and the latest policy changes. Particularly regarding the practical operations of pre-appraisal for R&D expense plus deductions, the lecturers combined specific cases to vividly demonstrate how to avoid subsequent tax risks through prior appraisal, ensuring that enterprises can fully enjoy the policy dividends. During the live Q&A session, representatives from Messi Biology actively interacted with the experts regarding the company’s actual R&D projects, discussing specific issues such as the establishment of auxiliary accounts for R&D expenses and the amortization of intangible assets. They received professional and detailed answers, finding the session immensely beneficial.
Hebei Messi Biology Co., Ltd. has always adhered to the innovation-driven development strategy, focusing on the R&D and production of high-end magnesium salt products such as magnesium oxide, magnesium carbonate, magnesium sulfate, and magnesium hydroxide, and is committed to providing high-quality raw material solutions for industries such as food, medicine, and chemical engineering. The company deeply understands that R&D investment is the source of maintaining its core competitiveness, while fully enjoying national tax preferential policies is an important guarantee for reducing R&D costs and increasing investment efforts. By participating in this training, the company’s management and relevant business personnel gained a more systematic and profound understanding of the R&D expense pre-plus deduction policy, as well as a clearer recognition of the importance and operational procedures of prior appraisal.
After the meeting, the attendees from Messi Biology stated that they would apply the knowledge learned from this training to practical work, further standardize the company’s R&D expense management, improve the documentation retention during the establishment and implementation of R&D projects, and actively utilize “prior appraisal” as a powerful tool to ensure that all tax preferential policies are fully enjoyed. In the future, Messi Biology will continue to increase its investment in scientific and technological innovation, enhance its independent innovation capabilities, and give back to the market with higher-quality products and services, contributing the “Messi” strength to the high-quality development of China’s magnesium salt industry.